5/19, 6:35 PM (Source: TeleTrader)
more TeleTrader news

Thousands to participate in UK jab booster trial - Hancock

British Health Secretary Matt Hancock stated on Wednesday thousands of people will receive the third, so-called "booster" shot of a vaccine against COVID-19 in the new clinical trial that starts today in the United Kingdom.

The study Cov-Boost, led by the University Hospital Southampton National Health Service (NHS) Foundation Trust and with the government's help worth £19.3 million, will include seven jabs. Three of them – the ones made by AstraZeneca PLC and Oxford University, Pfizer Inc. and BioNTech SE, and Moderna Inc. – are already in use in Britain. Four of them – manufactured by Johnson & Johnson (J&J), CureVac NV, Novavax Inc., and Valneva SE – are yet to be approved.

Hancock also urged the public to remain "vigilant" about the Indian variant of COVID-19, which is "more transmissible" than the one registered in Kent. Still, he stressed that the data collected so far showed the vaccines currently in use are effective against the strain and that the government's incumbent strategy to fight the pandemic is "the right one."

Breaking the News / JR